Groupe Bruxelles Lambert

Últimas notícias

Manchetes no idioma original da fonte.

• Novartis wagers almost $8B on a Chinese biotech’s RNA drugs (abre em uma nova aba)

  2 de out. de 2026

• 
  Novartis licenses Abogen mRNA autoimmune drug in $7.8B deal (abre em uma nova aba)

  2 de out. de 2026

• 
  Agios' Growth Story Hinges on Mitapivat's Commercial Expansion (abre em uma nova aba)

  2 de out. de 2026

• 
  Novartis Signs RNA Therapy Licensing Deal With China’s Abogen Worth Up to $7.8 Billion (abre em uma nova aba)

  2 de out. de 2026

• 
  Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs (abre em uma nova aba)

  2 de out. de 2026

• Groupe Bruxelles Lambert : GBL – Stemrechten en noemer – Situatie op 30 september 2026 (abre em uma nova aba)

  MarketScreener Nederland · 1 de out. de 2026

• Change in the holding of Suominen’s treasury shares (abre em uma nova aba)

  1 de out. de 2026

• Deutsche Bank lists Top European Stock picks for the next twelve months (abre em uma nova aba)

  1 de out. de 2026

• Suominen Corporation – Manager’s transaction: Charles Héaulmé (abre em uma nova aba)

  1 de out. de 2026

• Rezolv secures up to $636m for 1.3GWp Dama Solar project in Romania (abre em uma nova aba)

  1 de out. de 2026

• Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth (abre em uma nova aba)

  1 de out. de 2026

• Drug Repurposing Market - Global Strategic Business Report: Forecasts Growth to $37.3Billion by 2030, Profiling AbbVie, AstraZeneca, Pfizer, Novartis & Johnson & Johnson (abre em uma nova aba)

  30 de set. de 2026

• CAR T-Cell Therapy Market Forecasts Growth from $7.24B (2026) to $13.78B by 2031, Profiling Bristol-Myers Squibb, Gilead Sciences, Novartis & J&J (abre em uma nova aba)

  30 de set. de 2026

• Schweizer Electronic AG Transitions to the Scale Segment of the Frankfurt Stock Exchange (abre em uma nova aba)

  29 de set. de 2026

• CAS announces collaboration with Novartis to advance AI-ready reaction informatics (abre em uma nova aba)

  29 de set. de 2026

• Hungary’s OTP Bank weighs Russia exit amid Luminor purchase – report (abre em uma nova aba)

  29 de set. de 2026

• Global chip stocks rise as Anthropic spending outlook lifts AI demand hopes (abre em uma nova aba)

  29 de set. de 2026

• European equities give up gains despite oil decline and Anthropic’s outlook (abre em uma nova aba)

  29 de set. de 2026

• ARTHEx Biotech Announces Appointment of Glenn P. Sblendorio as Chairman of the Board (abre em uma nova aba)

  29 de set. de 2026

• 
  Groupe Bruxelles Lambert (ENXTBR:GBLB): Assessing Valuation After Recent Period of Steady Share Price Gains (abre em uma nova aba)

  Simply Wall St. · 4 de out. de 2025